These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3292395)

  • 21. Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes.
    Kranz DM; Eisen HN
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3375-9. PubMed ID: 2953028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C; Sebastiani S; Albanesi C; Merk HF; Puddu P; Girolomoni G; Cavani A
    J Immunol; 2000 Sep; 165(6):3058-64. PubMed ID: 10975816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. I. Cytotoxins produced by antigen-specific and natural killer-like CTL are dissimilar to classical lymphotoxins.
    Green LM; Stern ML; Haviland DL; Mills BJ; Ware CF
    J Immunol; 1985 Dec; 135(6):4034-43. PubMed ID: 2415596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.
    Liu CC; Jiang S; Persechini PM; Zychlinsky A; Kaufmann Y; Young JD
    J Exp Med; 1989 Jun; 169(6):2211-25. PubMed ID: 2786549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are lytic granules and perforin 1 involved in lysis induced by in vivo-primed peritoneal exudate cytolytic T lymphocytes?
    Berke G; Rosen D
    Transplant Proc; 1987 Feb; 19(1 Pt 1):412-6. PubMed ID: 3493559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T-cell granules: biochemical properties and functional specificity.
    Podack ER; Konigsberg PJ; Acha-Orbea H; Pircher H; Hengartner H
    Adv Exp Med Biol; 1985; 184():99-119. PubMed ID: 3875979
    [No Abstract]   [Full Text] [Related]  

  • 28. Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules.
    Verret CR; Firmenich AA; Kranz DM; Eisen HN
    J Exp Med; 1987 Nov; 166(5):1536-47. PubMed ID: 2445890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serine esterase and hemolytic activity in human cloned cytotoxic T lymphocytes.
    Ferguson WS; Verret CR; Reilly EB; Iannini MJ; Eisen HN
    J Exp Med; 1988 Feb; 167(2):528-40. PubMed ID: 3126252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
    J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases.
    Lavie G; Meruelo D; Aroyo K; Mandel M
    Int Immunol; 2000 Apr; 12(4):479-86. PubMed ID: 10744649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
    Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
    J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavior and Properties of Mature Lytic Granules at the Immunological Synapse of Human Cytotoxic T Lymphocytes.
    Ming M; Schirra C; Becherer U; Stevens DR; Rettig J
    PLoS One; 2015; 10(8):e0135994. PubMed ID: 26296096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic lymphocyte-derived lytic granules do not induce DNA fragmentation in target cells.
    Duke RC; Sellins KS; Cohen JJ
    J Immunol; 1988 Oct; 141(7):2191-4. PubMed ID: 2844898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal analysis in the ultrastructure of cell-to-cell interaction between a human glioma cell line and autologous tumor-specific cytotoxic T lymphocytes.
    Iwasaki K; Kikuchi H; Miyatake S; Oda Y; Yamashita J; Yamasaki T
    Cell Immunol; 1990 Mar; 126(1):164-75. PubMed ID: 2302738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.
    Mazzocchi A; Rodolfo M; Parmiani G; Anichini A
    Melanoma Res; 1991; 1(3):169-76. PubMed ID: 1841713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cytotoxic T lymphocyte-mediated lysis by ETYA: effect independent of arachidonic acid metabolism.
    Taylor AS; Howe RC; Morrison AR; Sprecher H; Russell JH
    J Immunol; 1985 Feb; 134(2):1130-5. PubMed ID: 2981259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and function of asialo GM1 in alloreactive cytotoxic T lymphocytes.
    Ting CC; Bluestone JA; Hargrove ME; Loh NN
    J Immunol; 1986 Oct; 137(7):2100-6. PubMed ID: 2944948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
    Allbritton NL; Nagler-Anderson C; Elliott TJ; Verret CR; Eisen HN
    J Immunol; 1988 Nov; 141(10):3243-8. PubMed ID: 3263417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.